Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Biotechnology Research International|July 14, 2012
Ethanol Production from Nondetoxified Dilute-Acid Lignocellulosic Hydrolysate by Cocultures of Saccharomyces cerevisiae Y5 and Pichia stipitis CBS6054Ping Wan, Dongmei Zhai, Zhen Wang, et al.BMC Bioinformatics|August 16, 2006
A novel data mining method to identify assay-specific signatures in functional genomic studiesDerrick K Rollins, Dongmei Zhai, Alrica L Joe, et al.International Journal of Chronic Obstructive Pulmonary Disease|February 20, 2016
The lung function profile of once-daily tiotropium and olodaterol via Respimat(®) is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler(®) (ENERGITO(®) study)Kai-Michael Beeh, Eric Derom, José Echave-Sustaeta, et al.Journal of Colloid and Interface Science|April 10, 2025
A bifunctional catalyst of CoO/NBC composite for high-performance rechargeable flexible zinc-air batteryQuanhu Sun, Zilin Chen, Keyi Dong, et al.Nanoscale|August 7, 2023
A novel catalyst derived from Co-ZIFs to grow N-doped carbon nanotubes for all-solid-state supercapacitors with high performanceYunlong Qi, Tian Lv, Zilin Chen, et al.Open Heart|December 3, 2021
Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) studyYoung-Soo Lee, Yong Seog Oh, Eue-Keun Choi, et al.Open Heart|November 13, 2020
Real-world evaluation of perception, convenience and anticoagulant treatment satisfaction of patients with atrial fibrillation switched from long-term vitamin K antagonist treatment to dabigatranEue-Keun Choi, Young-Soo Lee, Alan Koay Choon Chern, et al.European Journal of Internal Medicine|June 14, 2021
Low bleeding and thromboembolic risk with continued dabigatran during cardiovascular interventions: the GLORIA-AF studySake J van der Wall, Gregory Y H Lip, Christine Teutsch, et al.Pageof 1